A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Study Identifier
M17-377
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Plain Language Summary
Available Language(s): English, Japanese
Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Dermatology - Atopic Dermatitis
  • Study Drug
  • Upadacitinib
  • Placebo for upadacitinib
  • Topical Corticosteroids (TCS)
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    12 - 75 Years

    Protocol Summary

    The objective of this study is to assess the safety of upadacitinib combined with topical corticosteroids (TCS) in adolescent and adult participants in Japan with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.

    Study Locations

    Location
    Status
    Location
    Ichinomiya Municipal Hospital /ID# 205942
    Ichinomiya-shi, Aichi-ken, Japan, 491-8558
    Status
    Not applicable
    Location
    Central Clinic /ID# 206558
    Nagoya, Aichi-ken, Japan, 464-0821
    Status
    Not applicable
    Location
    Nagoya City University Hospital /ID# 207566
    Nagoya, Aichi-ken, Japan, 467-8602
    Status
    Not applicable
    Location
    Yasumoto Dermatology Clinic /ID# 206480
    Chikushino-shi, Fukuoka, Japan, 818-0083
    Status
    Not applicable
    Location
    Kiryu Dermatology Clinic /ID# 206044
    Fukuoka, Fukuoka, Japan, 813-0044
    Status
    Not applicable
    Location
    Medical Corporation Matsuo Clinic /ID# 207323
    Fukuoka, Fukuoka, Japan, 819-0373
    Status
    Not applicable
    Showing {first} - {last} of {total} Results